Macrophages and prognosis of oral squamous cell carcinoma: a systematic review
Oral Squamous Cell Carcinoma (OSCC) presents a tumor microenvironment rich in
inflammatory cells. Depending on the stimulus, macrophages can polarize in M1 or M2 …
inflammatory cells. Depending on the stimulus, macrophages can polarize in M1 or M2 …
Transforming growth factor‑β signaling in head and neck squamous cell carcinoma: Insights into cellular responses
X Pang, YL Tang, XH Liang - Oncology letters, 2018 - spandidos-publications.com
Head and neck squamous cell carcinoma (HNSCC) arises in the oral cavity, salivary glands,
larynx, pharynx, nasal cavity and paranasal sinuses, and is characterized by high morbidity …
larynx, pharynx, nasal cavity and paranasal sinuses, and is characterized by high morbidity …
[HTML][HTML] Mining TCGA database for genes of prognostic value in glioblastoma microenvironment
Glioblastoma (GBM) is one of the most deadly brain tumors. The convenient access to The
Cancer Genome Atlas (TCGA) database allows for large-scale global gene expression …
Cancer Genome Atlas (TCGA) database allows for large-scale global gene expression …
Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer
CM Carnielli, CCS Macedo, T De Rossi… - Nature …, 2018 - nature.com
Different regions of oral squamous cell carcinoma (OSCC) have particular histopathological
and molecular characteristics limiting the standard tumor− node− metastasis prognosis …
and molecular characteristics limiting the standard tumor− node− metastasis prognosis …
Cancer-associated fibroblasts drive glycolysis in a targetable signaling loop implicated in head and neck squamous cell carcinoma progression
Despite aggressive therapies, head and neck squamous cell carcinoma (HNSCC) is
associated with a less than 50% 5-year survival rate. Late-stage HNSCC frequently consists …
associated with a less than 50% 5-year survival rate. Late-stage HNSCC frequently consists …
A subtype of cancer-associated fibroblasts with lower expression of alpha-smooth muscle actin suppresses stemness through BMP4 in oral carcinoma
Cancer-associated fibroblasts (CAFs) demonstrate the characteristics of myofibroblast
differentiation by often expressing the ultrastructure of alpha-smooth muscle actin (αSMA) …
differentiation by often expressing the ultrastructure of alpha-smooth muscle actin (αSMA) …
Oral cancer: genetics and the role of precision medicine
CC Li, Z Shen, R Bavarian, F Yang… - Dental …, 2018 - dental.theclinics.com
Dent Clin N Am 62 (2018) 29–46 http://dx. doi. org/10.1016/j. cden. 2017.08. 002 dental.
theclinics. com 0011-8532/18/© 2017 Elsevier Inc. All rights reserved. diagnosed cancer …
theclinics. com 0011-8532/18/© 2017 Elsevier Inc. All rights reserved. diagnosed cancer …
Factors secreted by cancer-associated fibroblasts that sustain cancer stem properties in head and neck squamous carcinoma cells as potential therapeutic targets
S Álvarez-Teijeiro, C García-Inclán, MÁ Villaronga… - Cancers, 2018 - mdpi.com
This study investigates for the first time the crosstalk between stromal fibroblasts and cancer
stem cell (CSC) biology in head and neck squamous cell carcinomas (HNSCC), with the …
stem cell (CSC) biology in head and neck squamous cell carcinomas (HNSCC), with the …
[HTML][HTML] The histologic risk model is a useful and inexpensive tool to assess risk of recurrence and death in stage I or II squamous cell carcinoma of tongue and floor of …
N Sinha, MH Rigby, ML McNeil, SM Taylor, JRB Trites… - Modern Pathology, 2018 - Elsevier
Surgery is the mainstay of treatment for low-stage (stage I/II, ie, T1N0/T2N0) squamous cell
carcinoma of oral cavity. However, a significant percentage of low-stage squamous cell …
carcinoma of oral cavity. However, a significant percentage of low-stage squamous cell …
Efficacy and safety of anti‐EGFR agents administered concurrently with standard therapies for patients with head and neck squamous cell carcinoma: a systematic …
Y Tian, J Lin, Y Tian, G Zhang, X Zeng… - … journal of cancer, 2018 - Wiley Online Library
Agents targeting epidermal growth factor receptor (EGFR) are used to treat head and neck
squamous cell carcinoma (HNSCC); however, their efficacy and safety is poorly understood …
squamous cell carcinoma (HNSCC); however, their efficacy and safety is poorly understood …